Effects of a nonpeptide motilin receptor antagonist on proximal gastric motor function

British Journal of Clinical Pharmacology

Volumn 57, Issue 4, 2004, Pages 393-401

  Kamerling, Ingrid M C ^a   Van Haarst, Aernout D ^a   Burggraaf, Jacobus ^a   Schoemaker, Rik C ^a   De Kam, Marieke L ^a   Heinzerling, Hartmut ^b   Cohen, Adam F ^a   Masclee, Ad A M ^c  

^a CENTRE FOR HUMAN DRUG RESEARCH   (Netherlands)

^b Johnson Johnson Pharmaceutical R D   (United Kingdom)

^c LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Antagonist; Human and Barostat; Motilin; Stomach

Indexed keywords

MOTILIN; NONPEPTIDE MOTILIN RECEPTOR ANTAGONIST; PLACEBO; RWJ 68023; UNCLASSIFIED DRUG;

ADULT; ARTICLE; BAROSTAT; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DOUBLE BLIND PROCEDURE; DRUG ANTAGONISM; DRUG SAFETY; DRUG TOLERABILITY; GASTROINTESTINAL SYMPTOM; HUMAN; HUMAN EXPERIMENT; INFUSION; INFUSION PUMP; LIQUID CHROMATOGRAPHY; MALE; MASS SPECTROMETRY; MUSCLE CONTRACTION; NAUSEA; NORMAL HUMAN; PRIORITY JOURNAL; RADIOIMMUNOASSAY; RANDOMIZED CONTROLLED TRIAL; STOMACH MOTILITY; STOMACH MUSCLE; STOMACH VOLUME; VISUAL ANALOG SCALE;

ADOLESCENT; ADULT; DOUBLE-BLIND METHOD; HUMANS; MALE; MIDDLE AGED; MOTILIN; MOTOR NEURONS; RECEPTORS, GASTROINTESTINAL HORMONE; RECEPTORS, NEUROPEPTIDE; SENSATION; STOMACH;

EID: 1942455403     PISSN: 03065251     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2125.2003.02034.x     Document Type: Article

References (34)

1. Polak JM, Pearse AG, Heath CM. Complete identification of endocrine cells in the gastrointestinal tract using semithin-thin sections to identify motilin cells in human and animal intestine. Gut 1975; 16: 225-9.
2. Peeters TL, Vantrappen G, Janssens J. Fasting plasma motilin levels are related to the interdigestive motility complex. Gastroenterology 1980; 79: 716-9.
3. Kamerling IMC, Van Haarst AD, Burggraaf J et al. Exogenous motilin affects postprandial proximal gastric motor function and visceral sensation. Dig Dis Sci 2002; 47: 1732-6.
4. Malagelada JR. Gastrointestinal motor disturbances in functional dyspepsia. Scand J Gastroenterol Suppl 1991; 182: 29-32.
5. Tack J, Piessevaux H, Coulie B, Caenepeel P, Janssens J. Role of impaired gastric accommodation to a meal in functional dyspepsia. Gastroenterology 1998; 115; 1346-52.
6. Stanghellini V, Tosetti C, Paternico A et al. Risk indicators of delayed gastric emptying of solids in patients with functional dyspepsia. Gastroenterology 1996; 110: 1036-42.
7. Gorard DA, Farthing MJ. Intestinal motor function in irritable bowel syndrome. Dig Dis 1994; 12: 72-84.
8. Kellow JE, Phillips SF. Altered small bowel motility in irritable bowel syndrome is correlated with symptoms. Gastroenterology 1987; 92: 1885-93.
9. Fukudo S, Suzuki J. Colonic motility, autonomic function, and gastrointestinal hormones under psychological stress on irritable bowel syndrome. Tohoku J Exp Med 1987; 151: 373-85.
10. Sjölund K, Ekman R. Are gut peptides responsible for the irritable bowel syndrome (IBS)? Scand J Gastroenterol Suppl 1987; 130: 15-20.
11. Simren M, Abrahamsson H, Bjornsson ES. An exaggerated sensory component of the gastrocolonic response in patients with irritable bowel syndrome. Gut 2001; 48: 20-7.
12. Tack J, Peeters T. What comes after macrolides and other motilin stimulants? Gut 2001; 49: 317-8.
13. Talley NJ. Review article: functional dyspepsia - should treatment be targeted on disturbed physiology? Aliment Pharmacol Ther 1995; 9: 107-15.
14. Kamerling IMC, Van Haarst AD, Burggraaf J et al. Motilin effects on the proximal stomach in patients with functional dyspepsia and healthy volunteers. Am J Physiol Gastrointest Liver Physiol 2003; 284: G776-81.
15. Beavers MP, Gunnet JW, Hageman W et al. Discovery of the first non-peptide antagonist of the motilin receptor. Drug Des Discov 2001; 17: 243-51.
16. Depoortere I, Macielag MJ, Galdes A, Peeters TL. Antagonistic properties of [Phe(3),Leu(13)] porcine motilin. Eur J Pharmacol 1995; 286: 241-7.
17. Poitras P, Miller P, St Gagnon D, St-Pierre S. Motilin synthetic analogues and motilin receptor antagonists. Biochem Biophys Res Commun 1994; 205: 449-54.
18. Iwai T, Nakamura H, Takanashi H et al. Hypotensive mechanism of [Leu13]motilin in dogs in vivo and in vitro. Can J Physiol Pharmacol 1998; 76: 1103-9.
19. Takanashi H, Yogo K, Ozaki K et al. GM-109: a novel, selective motilin receptor antagonist in the smooth muscle of the rabbit small intestine. J Pharmacol Exp Ther 1995; 273: 624-8.
20. Whitehead WE, Delvaux M. Standardization of barostat procedures for testing smooth muscle tone and sensory thresholds in the gastrointestinal tract. The Working Team of Glaxo-Wellcome Research, UK. Dig Dis Sci 1997; 42: 223-41.
21. Azpiroz F, Malagelada JR. Gastric tone measured by an electronic barostat in health and postsurgical gastroparesis. Gastroenterology 1987; 92: 934-43.
22. Stubbs RJ, Hughes DA, Johnstone AM et al. The use of visual analogue scales to assess motivation to eat in human subjects: a review of their reliability and validity with an evaluation of new hand-held computerized systems for temporal tracking of appetite ratings. Br J Nutr 2000; 84: 405-15.
23. Kamerling IMC, Van Haarst AD, Burggraaf J et al. Dose-related effects of motilin on proximal gastrointestinal motility. Alimentary Pharmacol Therapeutics 2002; 16: 129-35.
24. Coulie B, Vandaele P, Tack J, Janssens J. Motilin increases tone of the gastric fundus in man. Gastroenterology 1997; 112: A1140.
25. Thielemans L, Van Depoortere IA, Bender E, Peeters TL. Demonstration of a functional motilin receptor in TE671 cells from human cerebellum. Brain Res 2001; 895: 119-28.
26. Depoortere I, Verlinden M, Thijs T, Van Assche G. The motilide ABT-299 selectively downregulates motilin receptors in different tissues. Evidence for motilin receptor subtyes. Gastroenterology 1999; 116: G4610.
27. Luiking YC, van Akkermans LM, d Peeters TL, van Berge H. Differential effects of motilin on interdigestive motility of the human gastric antrum, pylorus, small intestine and gallbladder. Neurogastroenterol Motil 2003; 15: 103-11.
28. Mitznegg P, Bloom SR, Domschke W, Domschke S, Wuensch E, Demling L. Pharmacokinetics of motilin in man. Gastroenterology 1977; 72: 413-6.
29. Modlin IM, Mitznegg P, Bloom SR. Motilin release in the pig. Gut 1978; 19: 399-402.
30. Ludtke FE, Muller H, Golenhofen K. Direct effects of motilin on isolated smooth muscle from various regions of the human stomach. Pflugers Arch 1989; 414: 558-63.
31. Peeters TL, Bormans V, Vantrappen G. Comparison of motilin binding to crude homogenates of human and canine gastrointestinal smooth muscle tissue. Regul Pept 1988; 23: 171-82.
32. Miller P, Roy A, St Pierre S, Dagenais M, Lapointe R, Poitras P. Motilin receptors in the human antrum. Am J Physiol Gastrointest Liver Physiol 2000; 278: G18-G23.
33. Strunz U, Domschke W, Mitznegg P et al. Analysis of the motor effects of 13-norleucine motilin on the rabbit, guinea pig, rat, and human alimentary tract in vitro. Gastroenterology 1975; 68: 1485-91.
34. Strunz U, Domschke W, Domschke S et al. Gastroduodenal motor response to natural motilin and synthetic position 13-substituted motilin analogues: a comparative in vitro study. Scand J Gastroenterol 1976; 11: 199-203.